Used in research and development for targeting TYRO3, a receptor tyrosine kinase involved in cell survival, proliferation, and immune regulation. This antibody serves as a reference tool in immunoassays to detect and quantify TYRO3 expression in biological samples. It supports studies in oncology, particularly in cancers where TYRO3 is overexpressed, such as leukemia, breast, and lung cancers. Also utilized in pharmacokinetic and pharmacodynamic studies during the development of TYRO3-targeted therapies. Its high specificity makes it suitable for flow cytometry, Western blotting, and immunohistochemistry applications. Plays a critical role in validating drug targets and evaluating therapeutic antibody performance in preclinical models.